India, Feb. 24 -- The world of gaming is buzzing with anticipation as Rockstar Games gears up for an exciting year filled with major releases. While fans eagerly await the arrival of Grand Theft Auto ... Read More
New Delhi, Feb. 24 -- SBC Exports share price gained on Monday despite a sharp sell-off in the Indian stock market. The small-cap stock, SBC Exports shares rose as much as 0.47% to Rs.19.16 apiece on ... Read More
Jammu, Feb. 24 -- BJP MP Anurag Thakur on Monday praised the Union Budget 2025-26, calling it a "roadmap for development" that will help realise Prime Minister Narendra Modi's vision of a 'Viksit Bhar... Read More
United Kingdom, Feb. 24 -- United Kingdom based NEC Software Solutions UK Limited has secured contract from Bedford Borough Council for Consolidated Contract - Incl. Revenue and Benefits Citizens Acce... Read More
United Kingdom, Feb. 24 -- United Kingdom based BSE TRAVEL LTD has secured contract from SUFFOLK COUNTY COUNCIL for 2025-02-18 09:00 - QOC760 Stowmarket to The Damara School, Thetford, Norfolk - AWARD... Read More
United States, Feb. 24 -- United States based BSE Performance LLC has secured contract from Dept Of Defense for 60T Critical Chiller Rental At Portsmouth Naval Shipyard W043 - Lease Or Rental Of Equip... Read More
United States, Feb. 24 -- United States based Kumabe HR, LLC has secured contract from Budget & Finance for Executive Search Firm Services for Recruitment of ERS Exec Dir. The value of the contrac... Read More
United Kingdom, Feb. 24 -- United Kingdom based BSE TRAVEL LTD has secured contract from Suffolk County Council Passenger Transport for 2025-02-24 09:00 - QOC714 Bury St Edmunds to Kingsbrook School, ... Read More
India, Feb. 24 -- Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 mg. (USRLD: Du... Read More
India, Feb. 24 -- Biocon Biologics (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon (BSE code: 532523, NSE: BIOCON), today announced that YESINTEK' (ustekinumab-kfce) is... Read More